Breast Cancer News and Research

Latest Breast Cancer News and Research

State roundup: Fla. groups ask Gov. for essential benefits hearings

In a reversal of a law passed 4 years ago, physicians in Massachusetts will now be allowed to accept "modest" meals and refreshments provided by pharmaceutical or medical device companies.

13 Aug 2012

Radiation therapy following lumpectomy may benefit older, early-stage breast cancer patients

For the majority of older, early-stage breast cancer patients, radiation therapy following breast conserving surgery may help prevent the need for a later mastectomy, according to research from The University of Texas MD Anderson Cancer Center.

13 Aug 2012

Radiation after lumpectomy helps prevent need for subsequent mastectomy in older women with early stage breast cancer

Contrary to clinical recommendations, older women with early stage breast cancer may want to undergo radiation after lumpectomy to help ensure that they will not need a mastectomy in the future. That is the conclusion of a new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society. The findings indicate that current thinking on the risks and benefits of radiation for early stage breast cancer in older women may be inaccurate.

13 Aug 2012

Highlights: New reports of problems at Parkland Hospital in Dallas; Mammogram rates did not rise under expanded Mass. coverage

Federal safety monitors produced a harsher critique of Parkland Memorial Hospital's reform efforts than recently portrayed by the hospital, finding ongoing dangers to patients from a botched surgery, medication errors and emergency care failures. Those problems, cited in a June compliance report obtained by The Dallas Morning News, were not disclosed in a Parkland summary released to The News two weeks ago.

12 Aug 2012

Fat transfers may benefit patients after breast reconstructive surgery

When Susan McLain, 49, underwent a double mastectomy, she never imagined that she would look and feel better after reconstructive surgery than she did before breast cancer.

10 Aug 2012

Combination therapy delays progression for metastatic breast cancer patients

Phase III trial results show that a combination of the aromatase inhibitor anastrozole and fulvestrant, an analog of estradiol that downgrades the estrogen receptor, is superior to anastrozole alone in prolonging progression-free survival in patients with metastatic breast cancer.

10 Aug 2012

Female voters are hot commodity for presidential candidates

On the campaign trail, President Barack Obama continues his efforts to shore up support among women voters, as GOP presidential hopeful Mitt Romney vies for working-class voters.

9 Aug 2012

Herceptin® could potentially be delivered via a standard injection

A new method of delivering a commonly used breast cancer drug could result in considerably less time spent in hospital for some women undergoing breast cancer treatment, according to the results of a Phase 3 trial published Online First in The Lancet Oncology.

9 Aug 2012

MedPage Today, CollabRx sign license agreement for Oncology Next

Tegal Corporation today announced that its recently acquired CollabRx, Inc., subsidiary signed an exclusive license agreement to provide a version of its proprietary Therapy Finder tool to MedPage Today, Everyday Health, Inc.'s rapidly growing online site that serves 96% of all oncologists and 1.6 million monthly online unique users.

9 Aug 2012

Inaugural event of National Women's Survivors Convention to be held in Nashville

In August 2013, Nashville will be the host city to the National Women's Survivors Convention (NWSC), a first of its kind national event designed to celebrate women cancer survivors.

9 Aug 2012

Old cardiac drug performs new tricks

An animal study has shown that the anti-angina drug ranolazine could significantly reduce the number of deaths from carbon monoxide poisoning.

8 Aug 2012

GTx reports revenue of $1.6 million for second quarter 2012

GTx, Inc. today provided a Company update and reported financial results for the second quarter of 2012.

8 Aug 2012

Clovis Oncology reports net loss of $15.7 million for second quarter 2012

Clovis Oncology, Inc. today reported financial results for the second quarter 2012, and provided an update on the progress of its clinical development programs and expected milestones for the rest of the year.

8 Aug 2012

New research hopes to uncover mystery behind breast cancer metastasis

If detected early, most cases of breast cancer are curable. But if the tumour has metastasized - or spread to a site outside of the breast - cure rates decline. A team of researchers from Lawson Health Research Institute and Western University have received $449,733 from the Canadian Breast Cancer Foundation - Ontario Region to study a rare subpopulation of tumour cells called cancer stem cells (CSCs) in hopes of uncovering the mystery behind metastasis.

8 Aug 2012

New class of drugs reduces adverse effects of cellular damage from cancer chemotherapy

Chemotherapy kills tumor cells, but it also wreaks havoc on the rest of the body. A team of researchers led by Igor Roninson of the South Carolina College of Pharmacy just reported the discovery of a new class of drugs that reduces the adverse effects of cellular damage from chemotherapy.

8 Aug 2012

Clinical trial targets breast cancer cells by injecting trastuzumab directly into the spinal fluid

In two to five percent of women with breast cancer, tumor cells migrate into the spinal fluid invading the tissue surrounding the brain and spinal cord called the meninges. While a rare complication, the condition is challenging because there is no agreed-upon standard of treatment, leaving little hope for patients affected. Northwestern Medicine- researchers are currently examining a novel approach to delivering an FDA approved drug that they hope will advance research for this type of cancer and lead to discoveries that may improve outcomes in the future.

7 Aug 2012

‘Chicken Wing’ clue to stroke risk in atrial fibrillation

Patients with atrial fibrillation who have a Chicken Wing left atrial appendage morphology are less likely to have a stroke than those with other morphologies, research suggests.

6 Aug 2012

Human-derived breast cancer xenografts allow revolution in individualized cancer care

Cell cultures are homogeneous. Human tumors are not. A University of Colorado Cancer Center study recently published in the journal Breast Cancer Research and Treatment reports the development of human-derived estrogen-positive (ER+) breast cancer models that retain their heterogeneity, allowing researchers to more accurately test drugs for this disease.

6 Aug 2012

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

Montefiore Medical Center has launched the nation's first fellowship program in Women's Physical Medicine and Rehabilitation (WPM&R), and established a new clinical program in this specialty.

6 Aug 2012

New sequencing approach can provide more effective method of BRCA1/2 mutational analysis

Individuals with mutations in BRCA1 and BRCA2 genes have a significantly higher risk of developing breast and ovarian cancers. Families at risk have been seeking genetic testing and counseling based on their mutation carrier status, but the standard method of direct sequencing is labor-intensive, costly, and it only targets a part of the BRCA1 and BRCA2 genes.

6 Aug 2012

Breast Cancer News and Research

Latest Breast Cancer News and Research

State roundup: Fla. groups ask Gov. for essential benefits hearings

Radiation therapy following lumpectomy may benefit older, early-stage breast cancer patients

Radiation after lumpectomy helps prevent need for subsequent mastectomy in older women with early stage breast cancer

Highlights: New reports of problems at Parkland Hospital in Dallas; Mammogram rates did not rise under expanded Mass. coverage

Fat transfers may benefit patients after breast reconstructive surgery

Combination therapy delays progression for metastatic breast cancer patients

Female voters are hot commodity for presidential candidates

Herceptin® could potentially be delivered via a standard injection

MedPage Today, CollabRx sign license agreement for Oncology Next

Inaugural event of National Women's Survivors Convention to be held in Nashville

Old cardiac drug performs new tricks

GTx reports revenue of $1.6 million for second quarter 2012

Clovis Oncology reports net loss of $15.7 million for second quarter 2012

New research hopes to uncover mystery behind breast cancer metastasis

New class of drugs reduces adverse effects of cellular damage from cancer chemotherapy

Clinical trial targets breast cancer cells by injecting trastuzumab directly into the spinal fluid

‘Chicken Wing’ clue to stroke risk in atrial fibrillation

Human-derived breast cancer xenografts allow revolution in individualized cancer care

Montefiore launches first fellowship program in Women's Physical Medicine and Rehabilitation

New sequencing approach can provide more effective method of BRCA1/2 mutational analysis

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in